Neutralization of B.1.617.2 variant through antibodies elicited by ChAdOx1‐S, BBIBP‐CorV, and Gam‐COVID‐Vac in an Argentinean cohort
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Medical Virology"
DOI: 10.1002/jmv.28286
Abstract: B.1.617.2 variant is characterized by several mutations in the genome, which increase immune evasion. Since neutralization strongly correlates with protection from symptomatic infection, neutralization resistance of this variant is of concern. Following the introduction of… read more here.
Keywords: corv; bbibp corv; infection; 617 variant ... See more keywords
The incidence of COVID-19 infection following emergency use authorization of BBIBP-CORV inactivated vaccine in frontline workers in the United Arab Emirates
Sign Up to like & getrecommendations! Published in 2022 at "Scientific Reports"
DOI: 10.1038/s41598-021-04244-1
Abstract: Based on the findings from the Phase III clinical trials of inactivated SARS COV-2 Vaccine, (BBIBP-CORV) emergency use authorization (EUA) was granted for the vaccine to frontline workers in the UAE. A prospective cohort study… read more here.
Keywords: bbibp corv; frontline workers; infection; incidence ... See more keywords
Durability of antibodies post vaccination with two doses of inactivated BBIBP-CorV vaccine
Sign Up to like & getrecommendations! Published in 2022 at "Current Medical Research and Opinion"
DOI: 10.1080/03007995.2022.2139969
Abstract: Abstract Background Breakthrough infections post-COVID-19 vaccination occur with the emerging variants of the SARS-CoV virus which might be either due to the newer variants escaping immune response or the waning of antibodies over time. However,… read more here.
Keywords: corv vaccine; vaccination; bbibp corv; post vaccination ... See more keywords
Immune persistence induced by two-dose BBIBP-CorV vaccine with different intervals, and immunogenicity and safety of a homologous booster dose in high-risk occupational population
Sign Up to like & getrecommendations! Published in 2022 at "Expert Review of Vaccines"
DOI: 10.1080/14760584.2022.2141711
Abstract: ABSTRACT Background The immune persistence of neutralizing antibodies elicited by BBIBP-CorV vaccines on day 0–14, 0–21 and 0–28 schedule, and the immunogenicity and safety of a homologous booster dose after different priming vaccination regimens is… read more here.
Keywords: persistence; booster dose; bbibp corv; homologous booster ... See more keywords
Immune responses to Sinopharm/BBIBP‐CorV in individuals in Sri Lanka
Sign Up to like & getrecommendations! Published in 2022 at "Immunology"
DOI: 10.1111/imm.13536
Abstract: As there are limited data of the immunogenicity of the Sinopharm/BBIBP‐CorV in different populations, antibody responses against different SARS‐CoV‐2 variants of concern and T cell responses, we investigated the immunogenicity of the vaccine, in individuals… read more here.
Keywords: bbibp corv; sinopharm bbibp; sri lanka; individuals sri ... See more keywords
Humoral immunity of BBIBP‐CorV (Sinopharm) in kidney transplant recipients: Is it time to revise vaccination strategies
Sign Up to like & getrecommendations! Published in 2022 at "Transplant Infectious Disease"
DOI: 10.1111/tid.13798
Abstract: The mortality of coronavirus disease 2019 (COVID‐19) is high in transplant patients, and effective vaccination is aimed to reduce severe disease and mortality. read more here.
Keywords: immunity bbibp; corv sinopharm; vaccination; bbibp corv ... See more keywords
Safety and efficacy of Sinopharm vaccine (BBIBP-CorV) in elderly population of Faisalabad district of Pakistan
Sign Up to like & getrecommendations! Published in 2022 at "Postgraduate Medical Journal"
DOI: 10.1136/postgradmedj-2022-141649
Abstract: Introduction The first case of novel SARS-COV-2 (COVID-19) in Pakistan was detected on 26 February 2020. Pharmacological and non-pharmacological strategies have been tried to lessen the mortality and morbidity burden. Various vaccines have been approved.… read more here.
Keywords: bbibp corv; safety efficacy; sinopharm vaccine; pakistan ... See more keywords
Safety and efficacy of Sinopharm vaccine (BBIBP-CorV) in elderly population of Faisalabad district of Pakistan.
Sign Up to like & getrecommendations! Published in 2022 at "Postgraduate medical journal"
DOI: 10.1136/postmj/postgradmedj-2022-141649
Abstract: INTRODUCTION The first case of novel SARS-COV-2 (COVID-19) in Pakistan was detected on 26 February 2020. Pharmacological and non-pharmacological strategies have been tried to lessen the mortality and morbidity burden. Various vaccines have been approved.… read more here.
Keywords: bbibp corv; safety efficacy; sinopharm vaccine; pakistan ... See more keywords
Generalized Pustular Psoriasis Flare-Up after Both Doses of BBIBP-CorV Vaccination in a Patient under Adalimumab Treatment: A Case Report
Sign Up to like & getrecommendations! Published in 2023 at "Case Reports in Dermatology"
DOI: 10.1159/000530074
Abstract: Abstract Generalized pustular psoriasis is a possibly serious condition that can be triggered by various factors. Previous studies show a slight likelihood of disease exacerbation subsequent to COVID-19 vaccination. Here, we present the first (to… read more here.
Keywords: bbibp corv; psoriasis flare; generalized pustular; case ... See more keywords
Immunogenicity and reactogenicity of a third dose of BNT162b2 vaccine for COVID-19 after a primary regimen with BBIBP-CorV or BNT162b2 vaccines in Lima, Peru
Sign Up to like & getrecommendations! Published in 2022 at "PLoS ONE"
DOI: 10.1371/journal.pone.0268419
Abstract: Background: The administration of a third (booster) dose of COVID-19 vaccines in Peru initially employed the BNT162b2 (Pfizer) mRNA vaccine. The national vaccination program started with healthcare workers who received BBIBP-CorV (Sinopharm) vaccine as primary… read more here.
Keywords: reactogenicity; bbibp corv; immunogenicity; bnt162b2 ... See more keywords
Adverse events following immunization with ChAdOx1 nCoV-19 and BBIBP-CorV vaccine: A comparative study among healthcare professionals of Nepal
Sign Up to like & getrecommendations! Published in 2022 at "PLoS ONE"
DOI: 10.1371/journal.pone.0272729
Abstract: Background Adverse events following immunization (AEFI) against SARS-CoV-2 are common as reported by clinical trials and contemporary evidence. The objective of the present study was to evaluate the local and systemic adverse events following vaccination… read more here.
Keywords: corv vaccine; chadox1 ncov; bbibp corv; vaccine ... See more keywords